Craig Herman, MD
Urology · Pompano Beach, FLNPI 1720130495
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Coloplast at 27.6% of the total. 2025 is the largest year on record at $99, 3.5 times the $28 reported in 2022. That places this record below the midpoint for urology clinicians in FL, where the typical reported total is $3,881.
Across 7 payments — averaging $24.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$47
- Olympus America Inc.$28
- EDAP Technomed Inc$28
- Dendreon Pharmaceuticals LLC$28
- Verity Pharmaceuticals Inc.$24
- Laborie Medical Technologies Corp.$13
Across 65 payments — averaging $16,447 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$827K
- Organon$191K
- AMAG Pharmaceuticals, Inc.$26K
- Myovant Sciences Inc.$11K
- Ferring International Pharmascience Center US$9K
- Janssen Research & Development, LLC$3K
- plus $2K from 2 others
What the payments were for
- Food & beverage$169100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 2 | $47 |
| Olympus America Inc. | 1 | $28 |
| EDAP Technomed Inc | 1 | $28 |
| Dendreon Pharmaceuticals LLC | 1 | $28 |
| Verity Pharmaceuticals Inc. | 1 | $24 |
| Laborie Medical Technologies Corp. | 1 | $13 |
How this compares
$169 in reported general payments places this provider in the 10th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 18 | $11,118 |
| Tamsulosin Hcl | 88 | $875 |
| Finasteride | 37 | $458 |
| NitrofurantoinNitrofurantoin Macrocrystal | 15 | $196 |
| Levofloxacin | 82 | $172 |
| CefuroximeCefuroxime Axetil | 14 | $124 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 69 | $86 |
| Ciprofloxacin Hcl | 11 | $74 |
| Sildenafil Citrate | 11 | $48 |
| Diazepam | 50 | $32 |
Paid to pharmacies, not to this prescriber.
Other urology in Pompano Beach
- Paul PeritoCoral Gables$3.6M
- Scott SellingerTallahassee$2.3M
- Mark Anthony GonzalgoMiami$1M
- Edward GheilerHialeah$655K
- Rolando RiveraNaples$437K
- Matthew ErcolaniVenice$416K
- Olubayo TojuolaOrlando$283K
- Juan SuarezCoral Gables$276K
- Michael McDonaldCelebration$272K
- Raymond PakJacksonville$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.